NCT04497610

SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem

• Status: Withdrawn
• Phase: —
• Study type: Observational
• Enrollment: 0 (actual)
• Sponsor: Instituto Costarricense de Investigaciones Clínicas ICIC · Academic / Other
• Sex: All
• Age: 7 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR tests.

Detailed description

BioSafety Technologies has developed a rapid detection test to clear people of COVID-19. A person can undergo an easy non-invasive test, to determine if they are: COVID-19 Clear (Negative) or Infected (Positive). The user-friendly process does not involve medically trained personnel. The study will compare TeraSystem test results against PCR test results. Persons participating will be persons having a PCR test as part of the Health System and consenting to participate.

Conditions

• COVID19

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Breath sample	Patient will blow into a tube 5 times.

Timeline

• Start date: 2022-11-01
• Primary completion: 2022-11-01
• Completion: 2022-11-01
• First posted: 2020-08-04
• Last updated: 2022-11-29

Locations

1 site across 1 country: Costa Rica